Search

Author/Creator Moren, James

1. Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis. (2nd January 2022)

Authors:
Johnston, Karissa; Popoff, Evan; Deighton, Alison; Dabirvaziri, Parisa; Harris, Linda; Thiry, Alexandra; Croop, Robert; Coric, Vladimir; L'Italien, Gilbert; Moren, James
Journal:
Expert review of pharmacoeconomics & outcomes research
Issue:
Volume 22:Number 1(2022)
Page Start:
155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine. Issue 6 (22nd May 2021)

Authors:
Popoff, Evan; Johnston, Karissa; Croop, Robert; Thiry, Alexandra; Harris, Linda; Powell, Lauren; Coric, Vladimir; L'Italien, Gilbert; Moren, James
Journal:
Headache
Issue:
Volume 61:Issue 6(2021)
Page Start:
906
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗